Goodman Noah
Kymera Therapeutics, Inc. · Chief Business Officer
Goodman Noah is listed in public filings as officer: Chief Business Officer. This Goodman Noah insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Kymera Therapeutics, Inc. (KYMR). Investors use Goodman Noah's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $4.5M50.2k shares | SellApr 14, 2026 | $121.2K1.3k shares | $90.00 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $4.5M51.5k shares | SellApr 10, 2026 | $174.7K2k shares | $87.35 | -- | |
| $5.1M58.7k shares | SellApr 9, 2026 | $268.0K3.1k shares | $86.62 | -- | |
| $4.9M56k shares | SellApr 9, 2026 | $232.6K2.7k shares | $87.11 | -- | |
| $4.8M53.5k shares | SellApr 9, 2026 | $222.5K2.5k shares | $89.00 | -- | |
| $1.3M61.8k shares | Grant / ExerciseApr 9, 2026 | $52.6K2.5k shares | $21.05 | -- | |
| $1.7M18.5k shares | Grant / ExerciseMar 2, 2026 | $1.7M18.5k shares | $90.10 | -- | |
| --59.3k shares | Grant / ExerciseMar 2, 2026 | Disclosure amount unavailable9.2k shares | -- | -- | |
| $2.1M100k shares | Grant / ExerciseApr 8, 2025 | $2.1M100k shares | $21.05 | -- | |
| --50.1k shares | Grant / ExerciseApr 8, 2025 | Disclosure amount unavailable50k shares | -- | -- |